|
CDB Seminars Thursday 23 May at 1pm __________________________ Thursday 30 May at 1pm
|
Professor Stephen Davies
|
Telephone: Lab - 020 7679 2126
|
View
Prof Davies' Lab Research website here and his Profile on the
School of Life and Medical Sciences here
Research Interests
The ultrastructural and molecular organisation of the neuronal
nucleus.
Research Description
The neuronal cell nucleus has a characteristic and
highly specialised organisation. The nucleolus appears to act as a central
organising region around which there is a complex organisation of subnuclear
structures, such as the perinucleolar rosette and a large perinucleolar cap of
heterochromatin. We are currently defining the molecular and ultrastructural
composition of these domains. The rosette is made up of 1-2 domains containing
the Cajal Body protein p80 coilin together with Nopp140 and the SMN complex, the
remainder contain Nopp140. The heterochromatin caps contain large areas of MeCP2
and are associated with smaller domains containing the chromosome centromeres or
the polycomb protein complex. All these areas are variably marked by
trimethylated histones. We are further defining this complex organisation by
comparing it with 1) the spatial patterns of gene expression occurring in
neurons in vivo and 2) the 3d spatial arrangement of genes within the nucleus of
defined neurons Why do we think that this complex arrangement of neuronal
nuclear structure is of importance for human neurological disease? We have shown
that in Huntington's disease the neuronal nucleus reorganises to accommodate a
large intranuclear inclusion such that the perinucleolar rosette is disrupted to
allow movement of the Cajal body like p80 coilin positve structure to attach to
the newly formed inclusion. This results in a profound rearrangement of the
nucleolar structure, dissociation away from defined chromosomal domains and
transcriptional dysregulation. Similar disruption of these structures occurs in
spinal muscular atrophy (SMA), fragile X tremor ataxia syndrome (FXTAS),
frontotemporal dementia (FTD) and autism spectrum disorder (ASD). We are
currently investigating the functional consequences of nuclear disruption in
these conditions.
Page last modified on 25 may 10 14:50 by Glenda Young

